Navigation Links
Inflammation Might Play Role in Heart Disease: Study
Date:3/14/2012

WEDNESDAY, March 14 (HealthDay News) -- A protein involved in inflammation appears to play a role in the development of coronary heart disease, new research indicates.

Coronary heart disease -- also known as hardening of the arteries -- is caused by plaque build-up in the small vessels that supply blood and oxygen to the heart.

The new findings suggest that drugs that target the protein interleukin-6 receptor (IL6R) in the body might help prevent coronary heart disease. One such drug, tocilizumab, is currently used to treat rheumatoid arthritis.

The articles appeared online March 13 in The Lancet.

In one analysis, researchers reviewed data from more than 200,000 people in 82 studies and found that those with a genetic variation of IL6R that dampens inflammation had a reduced risk of heart disease.

For each inherited copy of the genetic variation Asp358Ala, a person had a 3.4 percent reduced risk of coronary heart disease.

"These results support the inflammation hypothesis in coronary heart disease and encourage exploration of modulation of IL6R pathways as a means to prevent coronary heart disease," wrote researchers from the IL6R Genetics Consortium and Emerging Risk Factors Collaboration.

In the second analysis, researchers reviewed data from more than 133,000 people in 40 studies and found a 5 percent reduced risk of coronary heart disease for each inherited copy of the Asp358Ala variant.

"IL6R blockade could provide a novel therapeutic approach to prevention of coronary heart disease that warrants testing in suitably powered randomized trials," wrote the researchers with the IL6R Mendelian Randomization Analysis Consortium.

"Collectively, these large-scale and highly consistent results lend strong support to the concept that inhibition of inflammatory pathways is an attractive strategy to reduce cardiovascular risk," Matthijs Boekholdt and Erik Stroes, from the Academic Medical Center in Amsterdam, Netherlands, wrote in an accompanying editorial.

More information

The U.S. National Heart, Lung, and Blood Institute has more about coronary heart disease.

-- Robert Preidt

SOURCE: The Lancet, news release, March 12, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New class of compounds stops disease-fueling inflammation in lab tests
2. The balancing act between protection and inflammation in MS
3. NIH grant targets inflammation in link between obesity and disease
4. UIC researchers discover how cells limit inflammation in lung injury
5. BUSM researchers find link between pulmonary inflammation, diesel exhaust, house dust
6. Major cause of chronic kidney disease-related inflammation is identified
7. Titanium Joint Debris May Trigger Painful Inflammation
8. Ginger Supplements Might Ease Inflammation Linked to Colon Cancer
9. Imaging agents offer new view of inflammation, cancer
10. T cells making brain chemicals may lead to better treatments for inflammation, autoimmune diseases
11. Inflammation From Rheumatoid Arthritis Tied to Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Inflammation Might Play Role in Heart Disease: Study
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... 12, 2017   EcoVadis , the leading platform for environmental, social ... annual edition of its Global CSR Risk and Performance Index. The report ... based on Scorecard Ratings that analyzed nearly 800,000 data points across the ... ... ...
Breaking Medicine Technology: